Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors-Reference-Cited by-同舟云学术

Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors

Published:2021-01-07 Issue:2 Volume:30 Page:342-360
ISSN:1059-7700
Container-title:Journal of Genetic Counseling
language:en
Short-container-title:Jrnl of Gene Coun

Author:

Berliner Janice L.¹,Cummings Shelly A.²,Boldt Burnett Brittany³,Ricker Charité N.⁴

Affiliation:

1. Genetic Counseling Department Bay Path University East Longmeadow MA USA

2. Myriad Genetics, Inc Salt Lake City UT USA

3. Sharp HealthCare San Diego CA USA

4. Keck School of Medicine University of Southern California Los Angeles CA USA

Publisher

Wiley

Subject

Genetics(clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgc4.1374

Reference158 articles.

1. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population‐based biobank;Abul‐Husn N. S.;Genome Medicine,2019

2. updated recommendations regarding analysis and reporting of secondary findings in clinical genome‐scale sequencing;ACMG policy statement;Genetics in Medicine,2015

3. ACMG Policy Statement of the Social Ethical and Legal Issues Committee. (1999). Retrived fromhttps://www.acmg.net/PDFLibrary/Duty‐to‐Recontact.pdf

4. Hereditary breast and ovarian cancer syndrome;ACOG Committee on Practice Bulletins;Gynecologic Oncology,2009

5. Diagnostic Accuracy of the Gail Model in the Black Women?s Health Study

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements;International Journal of Molecular Sciences;2024-02-03

2. Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes;Journal of Genetic Counseling;2023-10-25

3. Implementation Mapping for Managing Patients at High Risk for Hereditary Cancer;American Journal of Preventive Medicine;2023-10

4. Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib;Clinical Breast Cancer;2023-07

5. Educational Case: Hereditary breast and ovarian cancers;Academic Pathology;2023-07